Publication Year

Fryzek J, Doucette A, Jiang X, Coalson J, McLaurin K, Ambrose CS. Trends in respiratory syncytial virus and bronchiolitis infant hospitalization rates in high-risk infants in a US nationally representative database (1997–2012). Presented at ID Week, San Diego, CA, October 2015.

Bottomley AL, Rowles A, Mitchell DJ, Rasmussen AD. 2015. Detection of mild and reversible neurohistopathological changes in the brain of juvenile (preweaned) beagle dogs treated with vigabatrin for up to 91 days. Toxicol Pathol 43(7):1015-24; doi: 10.1177/0192623315591838. PMID: 26157036.

Meddings J, Reichert H, Smith SN, McMahon LF Jr. How do hospital grades publicly displayed on Medicare’s Hospital Compare website compare to whether a hospital was penalized for readmissions and hospital-acquired conditions? Presented at the 2015 Agency for Heathcare Research and Quality (AHRQ) Research Conference, Crystal City, VA, October 4-6, 2015.

Wikoff D, Doepker C, Welsh B, Urban J, Henderson R, Britt J, Harvey S, Goldberger J, Myers E, O’Brien C, Peck J, Lieberman H, Weaver C, Tenebein M. 2015. Systematic review of the adverse bone and calcium balance effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children. PROSPERO 2015:CRD42015026609 Available from http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42015026609 (Systematic Review Protocol Registration)

Wikoff D, Doepker C, Welsh B, Urban J, Henderson R, Brorby G, Britt J, Harvey S, et al. 2015. Systematic review of the adverse cardiovascular effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children. PROSPERO 2015:CRD42015026673. Available from https://www.crd.york.ac.uk/PROSPERO/view/CRD42015026673 (Systematic Review Protocol Registration)

Ulrich K. Inhalation toxicology – Regulatory aspects for pharmaceuticals. Presentation to In Vitro Toxicology Society Annual Meeting, Birmingham, UK, 2015.

Ulrich K. Requirements of nonclinical inhalation studies for clinical development and registration. Presentation to British Society of Toxicological Pathologists (BSTP) — Continuing Education Symposium 4, Department of Pathology, Cambridge, UK, 2015.

Movva N, Babik I, Lobo MA. Effectiveness of the first exoskeletal garment (Playskin LiftTM) to improve reaching and object exploration in infants born with brain injury. Poster presentation at the Northeast Regional IDeA Conference, Bar Harbor, Maine, September 2015.

Greene N, Pennie W. 2015. Computational toxicology: Friend or foe? Toxicol Res 4(5):1159-1172; doi: 10.1039/c5tx00055f.

Kelsh MA, Chia VM. Historical comparator studies: Strengths, limitations, and analytical considerations in using historical pooled clinical data for evaluating efficacy and safety of new therapies. Presented at International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE) Boston, MA, August 25, 2015.

Suh M, Mittal L, Hirsch S, Valdes R, Bartlett C, Rohr A, Proctor D. 2015. Lung cancer risk in chromate production workers exposed to hexavalent chromium. Presented at Society of Toxicology 54th Annual Meeting, San Diego, CA, March 2015.

Wikoff D, White MC, Borghoff SJ, Haws LC. Evaluation of tetrabromobisphenol A (TBBPA)-induced endocrine-related target gene activity using high-throughput screening data from ToxCast. Presented at Society of Toxicology 54th Annual Meeting, San Diego, CA, March 2015.

Pierce JS, Abelmann A, Lotter JT, Comerford C, Keeton K, Finley BL. 2015. Characterization of naturally occurring airborne diacetyl concentrations associated with the preparation and consumption of unflavored coffee. Toxicol Rep 2(Aug 18):1200–1208; doi: 10.1016/j.toxrep.2015.08.006. PMID: 28962462.

Movva N, Babik I, Lobo MA. Reaching new levels with the Playskin LiftTM exoskeletal garment in infants born with brain injury. Poster presentation at the Undergraduate Research and Service Celebratory Symposium at UD, Newark, DE, August 2015.

Sacks NC, Burgess JF, Cabral HJ, McDonnell ME, Pizer SD. 2015. The effects of cost sharing on adherence to medications prescribed for concurrent use: Do definitions matter? J Manag Care Pharmacy 21(8):678–687; doi: 10.18553/jmcp.2015.21.8.678. PMID: 26233540.

Wheeler MW, Shao K, Bailer AJ. 2015. Quantile benchmark dose estimation for continuous endpoints. Environmetrics 26(5):363-72; doi: 10.1002/env.2432.

Thompson CM, Wolf JC, Elbekai RH, Paranjpe MG, Seiter JM,…, Suh M, Proctor DM,.., Haws LC, et al. 2015. Duodenal crypt health following exposure to Cr(VI): Micronucleus scoring, γ-H2AX immunostaining, and synchrotron x-ray fluorescence microscopy. Mut Res 789–790(Aug):61–66; doi: 10.1016/j.mrgentox.2015.05.004. PMID: 26232259.

Thompson CM, Young RR, Suh M, Dinesdurage HR, Elbekai RH, Harris MA, Rohr AC, Proctor DM. 2015. Assessment of the mutagenic potential of Cr(VI) in the oral mucosa of Big Blue® transgenic F344 rats. Environ Mol Mutagen 56(7):621-628; doi: 10.1002/em.21952. PMID: 26010270.

Young RR, Thompson CM, Dinesdurage HR, Elbekai RH, Suh M, Rohr AC, Proctor DM. 2015. A robust method for assessing chemically induced mutagenic effects in the oral cavity of transgenic Big Blue® rats. Environ Mol Mutagen 56(7):629-636; doi: 10.1002/em.21951. PMID: 25969955.

Gaffney SH, Abelmann A, Pierce JS, Glynn ME, Henshaw JL, McCarthy LA, Lotter JT, Liong M, Finley BL. 2015. Naturally occurring diacetyl and 2,3-pentanedione concentrations associated with roasting and grinding unflavored coffee beans in a commercial setting. Toxicol Rep 2(Aug 14):1171–1181; doi: 10.1016/j.toxrep.2015.08.003. PMID: 28962459.